Skip to main content
. 2005 May 28;52(3):695–710. doi: 10.1016/j.pcl.2005.02.010

Table 3.

Comparison of live attenuated influenza vaccine versus killed inactivated trivalent influenza vaccine

Factor LAIV TIV
Route Intranasal spray Intramuscular injection
Type of vaccine Live virus Killed virus
Number of strains in vaccine 2 type A and 1 type B 2 type A and 1 type B
Vaccine strains updated Annually Annually
Approved age and risk groups Healthy persons; age 5–49 y Persons ≥6 mo old